Page last updated: 2024-08-16

ribavirin and Renal Insufficiency

ribavirin has been researched along with Renal Insufficiency in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (30.00)29.6817
2010's14 (70.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arakawa, T; Hige, S; Karino, T; Kimura, M; Kuwata, Y; Nakajima, T; Ohmura, T; Ozeki, I; Sato, T; Toyota, J1
Blotner, S; Brennan, BJ; Grippo, JF; Magnusson, MO; Martin, P; Nieforth, K; Solsky, J; Wang, K; Wat, C; Wilkins, JJ1
Galati, G; Gallo, P; Menna, P; Minotti, G; Picardi, A; Salvatorelli, E; Vespasiani Gentilucci, U1
Arotçarena, R; Causse, X; Denis, J; Hagège, H; Henrion, J; Lesgourgues, B; Nalet, B; Pariente, A; Rémy, AJ1
Arizumi, T; Chishina, H; Hagiwara, S; Inoue, T; Kitai, S; Kouno, M; Kudo, M; Minami, Y; Takita, M; Ueshima, K; Yada, N1
Aboulker, JP; Barrail-Tran, A; Chevaliez, S; Cotte, L; Fournier, I; Lacombe, K; Molina, JM; Taburet, AM; Valantin, MA; Vincent, C1
Dybowska, D; Karwowska, K; Kozielewicz, D; Wietlicka-Piszcz, M1
Kattakuzhy, S; Kottilil, S; Tang, L; Ward, H; Wilson, E1
Craft, ZN; Kamal, KM; Koerner, PH; Miller, RT; Trombatt, WD1
Badri, PS; Eckert, D; Menon, RM; Mensing, S; Polepally, AR1
Lange, CM; Mücke, MM; Mücke, VT; Zeuzem, S1
Dixit, V; Fabrizi, F; Martin, P; Messa, P1
Albrecht, JK; Bloomer, JR; Boparai, N; Brass, CA; Brown, KA; Galler, GW; Ghalib, RH; Herrine, SK; Jiang, R; King, JW; McCone, J; McHutchison, JG; Melia, MT; Muir, AJ; Mullen, KD; Noviello, S; Nunes, FA; Ravendhran, N; Shiffman, ML; Sulkowski, MS1
Bessede, T; Buffet, C; Charpentier, B; Durrbach, A; Hassan, Q; Roche, B; Samuel, D1
Carenzi, S; Ciancio, A; Olivero, A; Rizzetto, M; Saracco, G1
Bruchfeld, A; Lindahl, K; Schvarcz, R; Söderberg, M; Ståhle, L1
Anaissie, EJ; Aslan, T; Barlogie, B; Desikan, R; Fassas, A; Mahfouz, TH; Pouli, A1
Brouwer, JT; Mathot, RA; Orlent, H; Schalm, SW; Van Bommel, EF; Vulto, AG1
Alric, L; Kamar, N; Rostaing, L1
Carriero, D; Dieterich, DT; Fabrizi, F; Martin, P; Park, J; Uriel, AJ1

Reviews

6 review(s) available for ribavirin and Renal Insufficiency

ArticleYear
Dual sofosbuvir and ribavirin therapy for chronic hepatitis C infection.
    Expert review of gastroenterology & hepatology, 2016, Volume: 10, Issue:1

    Topics: Antiviral Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Failure; Liver Transplantation; Recurrence; Renal Insufficiency; Ribavirin; Sofosbuvir

2016
Effects of Mild and Moderate Renal Impairment on Ombitasvir, Paritaprevir, Ritonavir, Dasabuvir, and Ribavirin Pharmacokinetics in Patients with Chronic HCV Infection.
    European journal of drug metabolism and pharmacokinetics, 2017, Volume: 42, Issue:2

    Topics: 2-Naphthylamine; Adolescent; Adult; Aged; Anilides; Antiviral Agents; Area Under Curve; Carbamates; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclopropanes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Kidney Function Tests; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Models, Biological; Proline; Renal Insufficiency; Ribavirin; Ritonavir; Sulfonamides; Uracil; Valine; Young Adult

2017
Special populations: treating hepatitis C in patients with decompensated cirrhosis and/or advanced renal impairment.
    Liver international : official journal of the International Association for the Study of the Liver, 2017, Volume: 37 Suppl 1

    Topics: Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Randomized Controlled Trials as Topic; Renal Insufficiency; Ribavirin; Sofosbuvir; Sustained Virologic Response

2017
Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials.
    Journal of viral hepatitis, 2011, Volume: 18, Issue:7

    Topics: Adult; Aged; Anemia; Antiviral Agents; Clinical Trials as Topic; Cohort Studies; Drug Therapy, Combination; Female; Heart Failure; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferon-beta; Interferons; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Renal Dialysis; Renal Insufficiency; Ribavirin; Treatment Outcome

2011
Therapy of chronic hepatitis C: a critical review.
    Current drug targets. Infectious disorders, 2003, Volume: 3, Issue:1

    Topics: Age Factors; Alanine Transaminase; Animals; Blood Coagulation Disorders, Inherited; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Genotype; Hepatitis C, Chronic; Humans; Interferon-alpha; Pregnancy; Recurrence; Renal Insufficiency; Ribavirin; Treatment Outcome

2003
Treatment of hepatitis C-virus-related glomerulonephritis.
    Kidney international, 2006, Volume: 69, Issue:3

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Glomerulonephritis, Membranoproliferative; Hepatitis C; Humans; Immunosuppressive Agents; Interferon-alpha; Proteinuria; Renal Insufficiency; Renin-Angiotensin System; Ribavirin; Rituximab

2006

Trials

3 trial(s) available for ribavirin and Renal Insufficiency

ArticleYear
Safety, tolerability, and pharmacokinetics of ribavirin in hepatitis C virus-infected patients with various degrees of renal impairment.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12

    Topics: Adult; Aged; Antiviral Agents; Area Under Curve; Drug Administration Schedule; Drug Dosage Calculations; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Metabolic Clearance Rate; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Renal Insufficiency; Ribavirin; Severity of Illness Index

2013
Telaprevir enhances ribavirin-induced anaemia through renal function impairment.
    Antiviral therapy, 2015, Volume: 20, Issue:5

    Topics: Anemia; Antiviral Agents; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Kidney; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Recombinant Proteins; Renal Insufficiency; Ribavirin

2015
Treatment of dialysis patients with chronic hepatitis C using pegylated interferon and low-dose ribavirin.
    The International journal of artificial organs, 2008, Volume: 31, Issue:4

    Topics: Adult; Aged; Anti-Retroviral Agents; Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Patient Dropouts; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Recurrence; Renal Dialysis; Renal Insufficiency; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome; Viral Load

2008

Other Studies

11 other study(ies) available for ribavirin and Renal Insufficiency

ArticleYear
Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C.
    Journal of viral hepatitis, 2014, Volume: 21, Issue:5

    Topics: Adult; Aged; Anemia; Antiviral Agents; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Oligopeptides; Renal Insufficiency; Ribavirin; Serum

2014
Telaprevir raises the plasma/whole blood ribavirin ratio: trying to come full circle on a dangerous relationship.
    Journal of viral hepatitis, 2014, Volume: 21, Issue:10

    Topics: Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Male; Oligopeptides; Renal Insufficiency; Ribavirin

2014
Renal dysfunction associated with telaprevir-containing triple therapy for chronic hepatitis C: is early prediction possible?
    European journal of gastroenterology & hepatology, 2014, Volume: 26, Issue:9

    Topics: Adult; Aged; Anemia; Antiviral Agents; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Hemoglobins; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Oligopeptides; Predictive Value of Tests; Prospective Studies; Renal Insufficiency; Retrospective Studies; Ribavirin; Risk Factors

2014
Efficacy and safety of telaprevir-based antiviral treatment for elderly patients with hepatitis C virus.
    Oncology, 2014, Volume: 87 Suppl 1

    Topics: Adult; Aged; Anemia; Antiviral Agents; Biomarkers; Drug Eruptions; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Male; Middle Aged; Oligopeptides; Renal Insufficiency; Ribavirin; Time Factors; Treatment Outcome; Viral Load

2014
Renal impairment in patients with chronic hepatitis C treated with first generation protease inhibitors.
    Expert opinion on drug safety, 2015, Volume: 14, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Drug Therapy, Combination; Female; Hemoglobins; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Renal Insufficiency; Retrospective Studies; Ribavirin; Risk Factors; Time Factors; Young Adult

2015
Retrospective Analysis of the Medication Utilization and Clinical Outcomes of Patients Treated with Various Regimens for Hepatitis C Infection.
    Journal of pharmacy practice, 2017, Volume: 30, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Cohort Studies; Drug Therapy, Combination; Drug Utilization; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Nausea; Polyethylene Glycols; Recombinant Proteins; Renal Insufficiency; Retrospective Studies; Ribavirin; Simeprevir; Sofosbuvir; Treatment Outcome; Young Adult

2017
Racial differences in hepatitis C treatment eligibility.
    Hepatology (Baltimore, Md.), 2011, Volume: 54, Issue:1

    Topics: Adult; Alcoholism; Antiviral Agents; Black People; Diabetes Complications; Eligibility Determination; Female; Heart Diseases; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Mass Screening; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Renal Insufficiency; Retrospective Studies; Ribavirin; Substance-Related Disorders; Treatment Outcome; United States; White People

2011
Liver-kidney recipients with chronic viral hepatitis C treated with interferon-alpha.
    Transplant international : official journal of the European Society for Organ Transplantation, 2012, Volume: 25, Issue:9

    Topics: Acute Disease; Adult; Aged; Biopsy; Female; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Interferon-alpha; Kidney Transplantation; Liver; Liver Failure; Liver Transplantation; Male; Middle Aged; Recurrence; Renal Insufficiency; Retrospective Studies; Ribavirin; Steroids; Transaminases; Treatment Outcome

2012
Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2003, Volume: 18, Issue:8

    Topics: Aged; Antiviral Agents; Chromatography, High Pressure Liquid; Creatinine; Female; Glomerulonephritis; Hepacivirus; Hepatitis C; Humans; Interferons; Kidney Diseases; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; Ribavirin; RNA, Viral; Vasculitis

2003
The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management.
    Blood, 2004, Mar-01, Volume: 103, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Body Fluids; Female; Humans; Immunoglobulins, Intravenous; L-Lactate Dehydrogenase; Male; Middle Aged; Multiple Myeloma; Multivariate Analysis; Neoplasms; Peripheral Blood Stem Cell Transplantation; Renal Insufficiency; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Time Factors

2004
Peginterferon and dose-titrated ribavirin for hepatitis C-associated nephrotic membranoproliferative glomerulonephritis type 1.
    Digestive diseases and sciences, 2005, Volume: 50, Issue:10

    Topics: Antiviral Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glomerulonephritis, Membranoproliferative; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Nephrotic Syndrome; Polyethylene Glycols; Recombinant Proteins; Renal Insufficiency; Ribavirin

2005